During the past decade, Inland Rheumatology; Clinical Trials, Inc. conducted 50 clinical trials. In the 10-year time frame, 50 clinical trials started and 47 clinical trials were completed, i.e. on average, 94% percent of trials that started reached the finish line to date. In the past 5 years, 17 clinical trials started and 24 clinical trials were completed. i.e. 141.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Inland Rheumatology; Clinical Trials, Inc." #1 sponsor was "Pfizer" with 12 trials, followed by "Eli Lilly and Company" with 11 trials sponsored, "Bristol-Myers Squibb" with 5 trials sponsored, "Amgen" with 4 trials sponsored and "Boehringer Ingelheim" with 4 trials sponsored. Other sponsors include 28 different institutions and companies that sponsored additional 28 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Inland Rheumatology; Clinical Trials, Inc." #1 collaborator was "Incyte Corporation" with 4 trials as a collaborator, "OCT Clinical Trials" with 3 trials as a collaborator, "Galapagos NV" with 2 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 2 trials as a collaborator and "PPD" with 2 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "Inland Rheumatology; Clinical Trials, Inc." are "Rheumatoid Arthritis" (27 trials), "Systemic Lupus Erythematosus" (12 trials), "Arthritis, Rheumatoid" (9 trials), "Lupus Erythematosus, Systemic" (7 trials) and "Low Back Pain" (2 trials). Many other conditions were trialed in "Inland Rheumatology; Clinical Trials, Inc." in a lesser frequency.

Most popular intervention types in "Inland Rheumatology; Clinical Trials, Inc." are "Drug" (61 trials), "Biological" (11 trials), "Other" (9 trials), "Device" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (24 trials), "Baricitinib" (7 trials), "Methotrexate" (4 trials), "Abatacept" (3 trials) and "Adalimumab" (3 trials). Other intervention names were less common.

The vast majority of trials in "Inland Rheumatology; Clinical Trials, Inc." are 68 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Inland Rheumatology; Clinical Trials, Inc.". undefined are not yet recruiting, 6 are recruiting, 6 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 48 completed trials in Inland Rheumatology; Clinical Trials, Inc., undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Inland Rheumatology; Clinical Trials, Inc., 1 "Phase 1" clinical trials were conducted, 29 "Phase 2" clinical trials and 30 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 12 trials, and there were also 0 trials that are defined as “Not Applicable".